{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:13:04Z","timestamp":1788243184681,"version":"build-2803163510"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2133","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T23:21:59Z","timestamp":1408058519000},"page":"1749-1754","source":"Crossref","is-referenced-by-count":3,"title":["A Pilot Study to Examine the Management of Asymptomatic Hyperparathyroidism in Japanese Patients in Accordance with the Guidelines for Asymptomatic PHPT Proposed at the Third International Workshop in 2008"],"prefix":"10.2169","volume":"53","author":[{"given":"Atsushi","family":"Ogo","sequence":"first","affiliation":[{"name":"Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Potts JT. Management of asymptomatic hyperparathyroidism. J Clin Endocrinol Metab 70: 1489-1493, 1990.","DOI":"10.1210\/jcem-70-6-1489"},{"key":"2","unstructured":"2. Bilezikian JP, Potts JT, Fuleihan Gel-H, et al. Summary statement from workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87: 5353-5361, 2002."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Khan AA, Bilezikian JP, Potts JT Jr. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab 94: 333-334, 2009.","DOI":"10.1210\/jc.2008-1757"},{"key":"4","unstructured":"4. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94: 335-339, 2009."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marcocci C, Cetani F. Primary hyperparathyroidism. N Engl J Med 365: 2389-2397, 2011.","DOI":"10.1056\/NEJMcp1106636"},{"key":"6","unstructured":"6. Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 21: 171-177, 2006."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lundgren E, Rastad J, Åkerström G, Ljunghall S. Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. Surgery 121: 287-294, 1997.","DOI":"10.1016\/S0039-6060(97)90357-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Abbas JS, Hashem SI, Faraj WG, Khalifeh MJ, Horani MH, Salti IS. The outcome of cervical exploration for asymptomatic and symptomatic patients with primary hyperparathyroidism. World J Surg 30: 69-75, 2006.","DOI":"10.1007\/s00268-005-0040-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hagstrom E, Lundgren E, Mallmin H, Rastad J, Hellman P. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Intern Med 259: 191-198, 2006.","DOI":"10.1111\/j.1365-2796.2005.01600.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mosekilde L. Primary hyperparathyroidism and the skeleton. Clin Endocrinol 69: 1-19, 2008.","DOI":"10.1111\/j.1365-2265.2007.03162.x"},{"key":"11","unstructured":"11. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94: 351-365, 2009."},{"key":"12","unstructured":"12. Frøkjaer VG, Mollerup CL. Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy. World J Surg 26: 532-535, 2002."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Odvina CV, Sakhaee K, Heller HJ, et al. Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 35: 123-128, 2007.","DOI":"10.1007\/s00240-007-0096-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bouzidi H, Brauwere D, Daudon M. Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism? Nephral Dial Transplant 26: 565-572, 2011.","DOI":"10.1093\/ndt\/gfq433"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg 231: 732-742, 2000.","DOI":"10.1097\/00000658-200005000-00014"},{"key":"16","unstructured":"16. Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg 33: 2256-2265, 2009."},{"key":"17","unstructured":"17. Udelsman R, Pasieka JL, Sturgeon C, Young JEM, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94: 366-372, 2009."},{"key":"18","unstructured":"18. Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism: an evidence-based analysis. Langenbecks Arch Surg 394: 765-784, 2009."},{"key":"19","unstructured":"19. Fang WL, Tseng LM, Chen JY, et al. The management of high-risk patients with primary hyperparathyroidism: minimally invasive parathyroidectomy vs. medical treatment. Clin Endocrinol 68: 520-528, 2008."},{"key":"20","unstructured":"20. Khan A, Grey A, Shoback D. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab 94: 373-381, 2009."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341: 1249-1255, 1999.","DOI":"10.1056\/NEJM199910213411701"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Caron NR, Pasieka JL. What symptom improvement can be expected after operation for primary hyperparathyroidism? World J Surg 33: 2244-2255, 2009.","DOI":"10.1007\/s00268-009-9987-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93: 3462-3470, 2008.","DOI":"10.1210\/jc.2007-1215"},{"key":"24","unstructured":"24. Sakuta A, Iijima T, Domeki N, et al. The etiology, clinical features aand management of hypercaicemia and its crisis. Dokkyo Igakkai Zasshi (Dokkyo J Med Sci) 39: 45-55, 2012 (in Japanese, Abstract in English)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/16\/53_53.2133\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T16:04:25Z","timestamp":1649952265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/16\/53_53.2133\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":24,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2133","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}